Laboratory News and Research

RSS

Cytori Therapeutics to initiate European medical device approval study for Celution System

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells for the treatment of heart attacks showed a substantial reduction in the size of injury to the heart, an improvement in the amount of blood supply to the heart muscle, and a corresponding functional improvement in the amount of blood the heart can pump.

7 May 2010

Manual provides laboratory methods, information and resources on new collection of model species

Mice, frogs, and E. coli are standard organisms in biology laboratories. But in the last few years, due in part to technical advances, the reduced costs of genome sequencing, and increased interest in evolution and development, the range of organisms used for research has greatly expanded. Scientists now have more flexibility in choosing a model system that might better address their specific research question.

7 May 2010

Closer to understanding age-related memory loss and drug to boost memory

The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.

7 May 2010

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

The Burnier International Ocular Pathology Society is holding a Scientific Colloquium in Montreal today to mark the tenth anniversary of the McGill University Health Centre's Henry C. Witelson Ocular Pathology Laboratory. The lab is an internationally reputed centre for the study and treatment of eye diseases and is leading a global network for the sharing of healthcare knowledge and expertise.

7 May 2010

DNA capture techniques enable sequencing of ancient Neandertal DNA

Researchers from the Max Planck Institute (MPI), Cold Spring Harbor Laboratory (CSHL), Agilent Technologies Inc., and other prestigious institutions worldwide have shown that DNA capture techniques can greatly enable the sequencing of ancient Neandertal DNA, providing new insight into the nature of these prehistoric hominids.

7 May 2010

Intellipharmaceutics generic Effexor XR ANDA accepted for filing by the FDA

Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).

7 May 2010

Gene patenting policies affect patient access to testing for disease-causing genes: Study

Policies allowing genes to be patented can make it more difficult for patients to access testing for important disease-causing gene mutations, according to a series of papers in a special online supplement published by Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.

7 May 2010

Postpartum hemorrhage increases 28% between 1995 and 2004

A new study of U.S. maternal outcomes after vaginal and cesarean deliveries published in the May 2010 issue of Anesthesia & Analgesia, a peer-reviewed academic journal, shows that between 1995 and 2004, postpartum hemorrhage (excessive blood loss after delivery) increased 28% in prevalence. Postpartum hemorrhage is one of today's most common complications for delivering mothers that according to the study, "markedly increases the odds of in-hospital mortality" and causes 19% of in-hospital maternal deaths.

7 May 2010

Study highlights benefits of using endometrial stem cells to restore functioning of brain cells

Stem cells derived from the endometrium (uterine lining) and transplanted into the brains of laboratory mice with Parkinson's disease appear to restore functioning of brain cells damaged by the disease, according to a new study by Yale School of Medicine researchers.

7 May 2010

Lifegene project launched to study origin of disease

The unique resources available in the Nordic region, such as civic registration numbers and the registries of genetically informative populations and health outcomes, make it an epidemiological goldmine. The LifeGene project is being coordinated by the Swedish medical university Karolinska Institutet to take advantage of Sweden's competitive edge in this field.

7 May 2010

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

Roche Diagnostics Canada announced today the launch of a new Health Canada approved clinical laboratory system designed to increase laboratory testing efficiency and to accommodate current and long-term molecular diagnostic needs. The cobas(R) 4800 System combines in vitro diagnostic tests for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and human papillomavirus (HPV) testing with fully-automated sample preparation and real-time polymerase chain reaction (PCR) technology.

From Roche Sequencing and Life Science 7 May 2010

THI at St. Luke's reveals new insights on how adult stem cells repair damaged hearts following heart attack

Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) are publishing research this week that reveals new insights into how a particular set of human adult stem cells helps repair damaged hearts following a heart attack in laboratory mice.

7 May 2010

DXA testing can prevent osteoporosis in at-risk women

Geisinger has exceeded the national benchmark for testing women who are at risk for developing osteoporosis - a silent and serious disease.

7 May 2010

CML HealthCare reports 2.3% decrease in first-quarter 2010 revenue

CML HealthCare Income Fund, today reported its financial results for the three month period ended March 31, 2010.

7 May 2010

Mouse study may lead to new therapies for Parkinson's disease

Endometrial stem cells injected into the brains of mice with a laboratory-induced form of Parkinson's disease appeared to take over the functioning of brain cells eradicated by the disease.

7 May 2010

Cytochroma reports positive results from Phase I trial for CTAP201 Injection in hemodialysis patients

Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.

6 May 2010

Biovail reports 27% increase in first-quarter 2010 total revenues

Biovail Corporation today announced its financial results for the three-month period ended March 31, 2010.

6 May 2010

Prescription drug may have new use in boosting effectiveness of vaccines for bacterial, viral diseases

A prescription drug already approved to treat genital warts and skin cancer may have a new use in boosting the effectiveness of future vaccines for bacterial and viral diseases, such as hepatitis C and HIV (the AIDS virus). These findings appear in ACS' Molecular Pharmaceutics, a bi-monthly journal.

6 May 2010

Scientists analyze genetic networks of microRNAs in tumors

Genes interact in complex networks that govern cellular processes, much like people connect a social network through relationships. Researchers are now discovering how biological networks change and are rewired in cancer.

6 May 2010

Home-based medical devices to grow over 1.6M by 2013: Report

Emerging Healthcare Solutions, Inc. applauded the results of a new report from InMedica on the world market for telemedicine, predicting that the use of home-based medical devices will drastically increase as telemedicine takes-off. According to the report, by 2013 the combined unit shipments of home-use digital blood-glucose meters, blood pressure monitors, weight scales, pulse oximeters and peak flow meters used in telemedical applications will grow to over 1.6 million.

6 May 2010

Laboratory News and Research

Cytori Therapeutics to initiate European medical device approval study for Celution System

Manual provides laboratory methods, information and resources on new collection of model species

Closer to understanding age-related memory loss and drug to boost memory

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

DNA capture techniques enable sequencing of ancient Neandertal DNA

Intellipharmaceutics generic Effexor XR ANDA accepted for filing by the FDA

Gene patenting policies affect patient access to testing for disease-causing genes: Study

Postpartum hemorrhage increases 28% between 1995 and 2004

Study highlights benefits of using endometrial stem cells to restore functioning of brain cells

Lifegene project launched to study origin of disease

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

THI at St. Luke's reveals new insights on how adult stem cells repair damaged hearts following heart attack

DXA testing can prevent osteoporosis in at-risk women

CML HealthCare reports 2.3% decrease in first-quarter 2010 revenue

Mouse study may lead to new therapies for Parkinson's disease

Cytochroma reports positive results from Phase I trial for CTAP201 Injection in hemodialysis patients

Biovail reports 27% increase in first-quarter 2010 total revenues

Prescription drug may have new use in boosting effectiveness of vaccines for bacterial, viral diseases

Scientists analyze genetic networks of microRNAs in tumors

Home-based medical devices to grow over 1.6M by 2013: Report

Pittcon 2024 - Advancing Science on the West Coast eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo